| Literature DB >> 31077569 |
Katherine Adlington1, James Smith1, Jason Crabtree1, Soe Win1, Jade Rennie1, Kuresh Khodatars1, Elisabeth Rosser2, Ian Hall1.
Abstract
Recent advances in genetic research have led to an increased focus on genetic causes of intellectual disability (ID) and have raised new questions about how and when clinicians offer genetic testing and the nature of communication around this decision with patients and carers. Determining the right approach to such discussions is complicated by complexities of communication, consent, and capacity and ethical concerns about genetic testing in this population. In this article, we briefly discuss the recent advances in genetic research relevant to people with intellectual disability, highlighting the challenges that might arise when undertaking genetic testing in this population. We then describe how we have used a Quality Improvement methodology to develop a clinical pathway for routine genetic testing for adults with intellectual disability in a clinical setting in East London.Entities:
Keywords: capacity; ethics; intellectual disability; neuropsychiatic genetics
Mesh:
Year: 2019 PMID: 31077569 DOI: 10.1002/ajmg.b.32732
Source DB: PubMed Journal: Am J Med Genet B Neuropsychiatr Genet ISSN: 1552-4841 Impact factor: 3.568